Artwork

Contenuto fornito da Gunnar Esiason. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Gunnar Esiason o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Episode 9: Turning Hope into Action with Dr. David Fajgenbaum and the Castleman Disease Collaborative Network

26:24
 
Condividi
 

Manage episode 337444525 series 3381207
Contenuto fornito da Gunnar Esiason. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Gunnar Esiason o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Dr. David Fajgenbaum joins Gunnar on the podcast to talk about his New York Times Bestselling book, "Chasing My Cure: A Doctor’s Race to Turn Hope Into Action" and his journey from division 1 college football quarterback and medical student to a rare disease patient up against the clock to find a treatment for his suddenly diagnosed Castleman Disease. Gunnar and Dr. Fajgenbaum talk about the hurdles that often stand in front of rare disease patient populations like decentralized patient organizations, a lack of a single scientific strategy and the absence of capital required for therapeutic development. Dr. Fajgenbaum has taken those challenges in stride and founded the Castleman Disease Collaborative Network hopes that he and his colleagues can centralize the needs of the patient community while working with all stakeholders from patients and physicians to family members and researchers. Gunnar and David also talk about the parallels between Castleman Disease and COVID-19, how patients who are not medical students or medical savvy can overcome the technical barrier between patients and providers, and how repurposing existing drug designed to target other conditions could be used to help people living with rare or ultra rare diseases.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

  continue reading

23 episodi

Artwork
iconCondividi
 
Manage episode 337444525 series 3381207
Contenuto fornito da Gunnar Esiason. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Gunnar Esiason o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Dr. David Fajgenbaum joins Gunnar on the podcast to talk about his New York Times Bestselling book, "Chasing My Cure: A Doctor’s Race to Turn Hope Into Action" and his journey from division 1 college football quarterback and medical student to a rare disease patient up against the clock to find a treatment for his suddenly diagnosed Castleman Disease. Gunnar and Dr. Fajgenbaum talk about the hurdles that often stand in front of rare disease patient populations like decentralized patient organizations, a lack of a single scientific strategy and the absence of capital required for therapeutic development. Dr. Fajgenbaum has taken those challenges in stride and founded the Castleman Disease Collaborative Network hopes that he and his colleagues can centralize the needs of the patient community while working with all stakeholders from patients and physicians to family members and researchers. Gunnar and David also talk about the parallels between Castleman Disease and COVID-19, how patients who are not medical students or medical savvy can overcome the technical barrier between patients and providers, and how repurposing existing drug designed to target other conditions could be used to help people living with rare or ultra rare diseases.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

  continue reading

23 episodi

Tutti gli episodi

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida

Ascolta questo spettacolo mentre esplori
Riproduci